Phytochemical and Pharmacological Screening of Crocus Sativus for Its Potential in Experimental Induced Neuropathic Pain in Rat
Year: 2026
Type: article
Abstract: Cisplatin is a widely used anticancer drug; however, its clinical application is often associated with peripheral neuropathy, which is characterised by impaired motor coordination, altered sensory responses, oxidative stress and inflammation. The present study was designed to evaluate the potential neuroprotective activity of the hydroalcoholic extract of Crocus sativus against cisplatin-induced neuropathy in experimental animals. The powdered plant material was subjected to physicochemical evaluation, followed by hydroalcoholic extraction and phytochemical screening. The percentage yield of the extract was found to be 4.28% w/w. Phytochemical screening revealed the presence of alkaloids, flavonoids, phenols, carbohydrates, saponins and tannins. The total flavonoid and total phenolic contents were estimated to be 0.685 and 0.719 mg/100 mg of dried extract, respectively. The neuroprotective potential was evaluated by assessing behavioural parameters, including rota-rod retention time, cold allodynia response and hot plate latency. Oxidative stress markers, including malondialdehyde (MDA), superoxide dismutase (SOD), glutathione (GSH) and catalase (CAT), were also investigated, along with the inflammatory marker tumour necrosis factor-alpha (TNF-α).
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7236685330
